(Q36943758)

17 August 2017

1 reference

title

In situ production of sex steroids in human breast carcinoma (English)

1 reference

17 August 2017

7

Hironobu Sasano

1 reference

17 August 2017

2

Yasuhiro Miki

1 reference

17 August 2017

1

Takashi Suzuki

1 reference

17 August 2017

3

Takuya Moriya

1 reference

17 August 2017

5

Hisashi Hirakawa

1 reference

17 August 2017

6

Noriaki Ohuchi

1 reference

17 August 2017

4

Jun-Ichi Akahira

1 reference

17 August 2017

publication date

18 September 2007

1 reference

Medical Molecular Morphology

17 August 2017

published in

1 reference

17 August 2017

volume

40

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

121-127

1 reference

https://scigraph.springernature.com/pub.10.1007/s00795-007-0365-8

17 August 2017

exact match

0 references

cites work

Short-term primary culture of epithelial cells derived from human breast tumours

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00795-007-0365-8

Steroid 5 alpha-reductase: two genes/two enzymes

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00795-007-0365-8

Androgen receptor expression in ductal carcinoma in situ of the breast: relation to oestrogen and progesterone receptors

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00795-007-0365-8

Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

21 January 2018

1 reference

12 December 2020

17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue.

1 reference

12 December 2020

Presence of alternatively spliced transcripts of aromatase gene in human breast cancer.

1 reference

12 December 2020

The 4-pregnene and 5alpha-pregnane progesterone metabolites formed in nontumorous and tumorous breast tissue have opposite effects on breast cell proliferation and adhesion

1 reference

12 December 2020

Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001

1 reference

12 December 2020

Steroid sulfatase: molecular biology, regulation, and inhibition.

1 reference

12 December 2020

Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene

1 reference

12 December 2020

Treatment of DCIS--results from clinical trials

1 reference

12 December 2020

Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.

1 reference

12 December 2020

Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma.

1 reference

12 December 2020

The selective estrogen enzyme modulators in breast cancer: a review

1 reference

12 December 2020

Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptor

1 reference

12 December 2020

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma

1 reference

12 December 2020

Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines

1 reference

12 December 2020

In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway

1 reference

12 December 2020

Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast.

1 reference

12 December 2020

Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling

1 reference

12 December 2020

The receptor expression pattern in ductal carcinoma in situ predicts recurrence

1 reference

12 December 2020

Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer

1 reference

12 December 2020

Risk of subsequent invasive breast cancer after breast carcinoma in situ

1 reference

12 December 2020

17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast

1 reference

12 December 2020

Significance of aromatase activity in human breast cancer

1 reference

12 December 2020

Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta

1 reference

12 December 2020

Prevention of hormone-related cancers: breast cancer

1 reference

12 December 2020

Intratumoral aromatase as a prognostic factor in human breast carcinoma

1 reference

12 December 2020

Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ

1 reference

12 December 2020

Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors

1 reference

12 December 2020

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues

1 reference

12 December 2020

Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives

1 reference

12 December 2020

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

1 reference

12 December 2020

Sex steroid-producing enzymes in human breast cancer

1 reference

12 December 2020

Interactions between prostaglandin E(2), liver receptor homologue-1, and aromatase in breast cancer

1 reference

12 December 2020

Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines

1 reference

12 December 2020

Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells

1 reference

12 December 2020

Biology of ductal carcinoma in situ classification based on biologic potential

1 reference

12 December 2020

Aromatase regulation and breast cancer

1 reference

12 December 2020

17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters

1 reference

12 December 2020

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

12 December 2020

Endogenous steroids in the pathophysiology of breast cancer

1 reference

12 December 2020

5Alpha-reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production

1 reference

12 December 2020

Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor

1 reference

12 December 2020

Regulation of estradiol 17 beta-hydroxysteroid dehydrogenase expression and activity by retinoic acid in T47D breast cancer cells

1 reference

12 December 2020

Structure-function aspects and inhibitor design of type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3)

1 reference

12 December 2020

Retinoid receptors in human breast carcinoma: possible modulators of in situ estrogen metabolism

1 reference

12 December 2020

Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium

1 reference

12 December 2020

Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues

1 reference

12 December 2020

Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers

1 reference

12 December 2020

Abnormal expression of 17beta-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence.

1 reference

12 December 2020

Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase

1 reference

12 December 2020

Second cancers followingin situ carcinoma of the breast

1 reference

12 December 2020

Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors

1 reference

12 December 2020

Localization of Estrone Sulfatase in Human Breast Carcinomas

1 reference

12 December 2020

5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions

1 reference

12 December 2020

Aromatase activity in breast tissue

1 reference

12 December 2020

17 beta-hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin

1 reference

12 December 2020

New trends of immunohistochemistry for making differential diagnosis of breast lesions

1 reference

12 December 2020

Enzymes as modulators in malignant transformation

1 reference

12 December 2020

Inhibition of cell cycle kinetics and proliferation by the androgen 5 alpha-dihydrotestosterone and antiestrogen N,n-butyl-N-methyl-11-[16' alpha-chloro-3',17 beta-dihydroxy-estra-1',3',5'-(10')triene-7' alpha-yl] undecanamide in human breast cancer

1 reference

12 December 2020

Prognostic value of breast cancer aromatase

1 reference

12 December 2020

Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor

1 reference

12 December 2020

MRI of the breast: comparison of MRI signals and histological characteristics of the same slices

1 reference

12 December 2020

Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone

1 reference

12 December 2020

Steroid 5alpha-reductases and 3alpha-hydroxysteroid dehydrogenases: key enzymes in androgen metabolism

1 reference

12 December 2020

Male pseudohermaphroditism caused by mutations of testicular 17 beta-hydroxysteroid dehydrogenase 3

1 reference

12 December 2020

Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ

1 reference

12 December 2020

High expression of steroid sulfatase mRNA predicts poor prognosis in patients with estrogen receptor-positive breast cancer.

1 reference

12 December 2020

10.1007/S00795-007-0365-8

Identifiers

DOI

1 reference

17 August 2017

1 reference